Abbott, Pfizer in pact for lung cancer screening
August 27, 2009
sam wrote an intriguing post today on
Here’s a little taster
CHICAGO (Reuters) – An Abbott Laboratories Inc unit that makes genetic tests will work with Pfizer Inc to develop a test to screen non-small cell lung cancer (NSCLC) tumors to determine which patients are good candidates for a novel cancer therapy being developed by Pfizer.
Read the rest of this post here
Posted in Prevention, Research
